It may have been a spirit of "irrational exuberance" that sparked a surge of new construction and a flood of private investment in the life sciences following the Covid pandemic, but that surge is now being tempered by reality.

Former Fed chairman Alan Greenspan coined the phrase "irrational exuberance" to describe the risk of unduly escalated asset values during the dot-com bubble of the 1990s. A new report on office space by CommercialEdge suggests a similar pattern in the life sciences since 2020.

"It has become clear that developers over-responded to demand for lab space, leading to a supply glut in the sector," the report stated. "Breakthroughs in mRNA and CRISPR technologies, alongside record low interest rates, led to billions of dollars in funding from both private and public sources pouring into the life sciences sector. Developers rushed to respond, bringing millions of square feet to market in recent years through new developments and conversions of existing buildings."

Continue Reading for Free

Register and gain access to:

  • Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
NOT FOR REPRINT

© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.